609 kr

Beställningsvara. Skickas inom 7-10 vardagar
Fri frakt för medlemmar vid köp för minst 249 kr.
There is substantial contemporary interest in psychedelic agents as medicines for maladies of the mind. This follows research in the 1950s and 1960s exploring the use of LSD and other psychedelics to treat a range of psychiatric illnesses as well as addictions. This research was shut down after prohibition of these drugs, however the last decade has seen a major renewal of interest in the therapeutic use of psychedelics and related drugs in psychiatry. Psilocybin (found in 'magic mushrooms') has been used effectively for amelioration of distress in people with depression/anxiety in the context of potentially life-ending cancers, as well as for treatment-resistant depression and also addictions. MDMA ('ecstasy') has shown efficacy for severe post-traumatic stress disorder, with enduring benefit. Other psychedelics, both plant-derived (e.g., ayahuasca) and synthetically produced (e.g., LSD) are also being investigated for their potential therapeutic value. These agents not only herald a new neurobiology but also allow an integration of psychotherapy with biological compounds that is truly novel and that challenges established psychiatric practice. Furthermore, the action of these agents on the brain allows an exploration of how the brain works to 'open up' to psychotherapeutic healing. Published as part of the Oxford Psychiatry Library series, the book provides an overview of this hugely exciting field, covering the history of psychedelics, clinical aspects, risks and side effects, precautions and processes.

Produktinformation

  • Utgivningsdatum2023-03-30
  • Mått140 x 217 x 10 mm
  • Vikt212 g
  • FormatHäftad
  • SpråkEngelska
  • SerieOxford Psychiatry Library
  • Antal sidor160
  • FörlagOUP OXFORD
  • ISBN9780192863607

Tillhör följande kategorier

Du kanske också är intresserad av

Cognition in Major Depressive Disorder

Cognition in Major Depressive Disorder

Roger S. McIntyre, Danielle S. Cha, Joanna K. Soczynska, Canada) McIntyre, Roger S. (, Mood Disorders Psychopharmacology Unit, University of Toronto, Canada) Cha, Danielle S. (, Mood Disorders Psychopharmacology Unit, University of Toronto, Canada) Soczynska, Joanna K. (, Mood Disorders Psychopharmacology Unit, University of Toronto, Danielle Cha, Roger S Mcintyre, Joanna K Soczynska

569 kr

Schizophrenia and Psychiatric Comorbidities

Schizophrenia and Psychiatric Comorbidities

David J. Castle, Peter F. Buckley, Rachel Upthegrove, Australia) Castle, David J. (Professor and Chair of Psychiatry, St Vincent's Hospital, The University of Melbourne, GA USA) Buckley, Peter F. (Professor of Psychiatry and Dean, Medical College of Georgia, Georgia Regents University, Augusta, UK) Upthegrove, Rachel (Reader in Psychiatry and Youth Mental Health, and Consultant Psychiatrist, Institute for Mental Health, University of Birmingham, David J Castle, Peter F Buckley

599 kr

Bipolar Disorder

Bipolar Disorder

Lakshmi Yatham, Gin Malhi, Canada) Yatham, Lakshmi (Professor of Psychiatry, Vice Chair for Research and International Affairs, Department of Psychiatry, The University of British Columbia, Vancouver, British Columbia, Australia) Malhi, Gin (Professor and Head, Discipline of Psychiatry, Sydney Medical School, University of Sydney, Director CADE Clinic, Royal North Shore Hospital, Sydney

729 kr

Cognitive Dimensions of Major Depressive Disorder

Cognitive Dimensions of Major Depressive Disorder

Bernhard T. Baune, Lab Division of Molecular Neurobiology of Mental Health University of Munster GERMANY) Baune, Bernhard T. (Department of Mental Health Director, Department of Mental Health Director, Bernhard T Baune

489 kr

Treatment Response and Resistance in Schizophrenia

Treatment Response and Resistance in Schizophrenia

Oliver Howes, Oliver Howes, Professor of Molecular Psychiatry) Howes, Oliver (King's College London, London, King's College London, London

539 kr

Generalized Anxiety Disorders

Generalized Anxiety Disorders

Michael Van Ameringen, Mark Pollack M.D, Canada.) Van Ameringen, Michael (Associate Professor, Department of Psychiatry and Behavioural Neurosciences, McMaster University, and Co-Director of the Anxiety Disorders Clinic, McMaster University Medical Centre, Hamilton Health Sciences, Hamilton, Ontario, USA) Pollack M.D, Mark (Grainger Professor and Chairmain, Department of Psychiatry, Rush University Medical Center, Mark H. Pollack

599 kr

Panic Disorder and Agoraphobia

Panic Disorder and Agoraphobia

Borwin Bandelow, Katharina Domschke, David Baldwin, Germany) Bandelow, Borwin (Specialist in Neurology and Psychiatry, Specialist in Neurology and Psychiatry, Department of Psychiatry and Psychotherapy, University of Gottingen, Germany) Domschke, Katharina (, Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wurzburg, UK) Baldwin, David (Reader, Reader, Department of Psychiatry, University of Southampton

689 kr

Managing Negative Symptoms of Schizophrenia

Managing Negative Symptoms of Schizophrenia

Bitter, BITTER, István Bitter, Hungary) Bitter, Istvan (Professor, Professor, Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest

659 kr

Addiction

Addiction

David J. Nutt, Liam J. Nestor, Imperial College London) Nutt, David J. (The Edmond J Safra Chair in Neuropsychopharmacology, The Edmond J Safra Chair in Neuropsychopharmacology, Centre for Neuropsychopharmacology, Division of Brain Sciences, Department of Medicine, Imperial College London) Nestor, Liam J. (Research Fellow, Research Fellow, Centre for Neuropsychopharmacology, Division of Brain Sciences, Department of Medicine, Nestor Nutt, NESTOR NUTT

669 kr

Physical Health and Schizophrenia

Physical Health and Schizophrenia

David J. Castle, Peter F. Buckley, Fiona P. Gaughran, Australia) Castle, David J. (Professor and Chair of Psychiatry, Professor and Chair of Psychiatry, St Vincent's Hospital, The University of Melbourne, USA) Buckley, Peter F. (Dean, Dean, School of Medicine, Virginia Commonwealth University, Richmond, UK.) Gaughran, Fiona P. (Lead Consultant in the National Psychosis Service and R&D Director, Lead Consultant in the National Psychosis Service and R&D Director, South London and Maudsley NHS Foundation Trust and Reader in Psychopharmacology and Physical Health at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN), London, David J Castle, Peter F Buckley, Fiona P Gaughran

579 kr